Page 1 of Clinical Trials for Anti-tumor activity, 1159 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma
Last Updated: June 6, 2011
Condition(s): Metastatic Melanoma
2
Withdrawn
A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer
Last Updated: February 1, 2010
Condition(s): Breast Cancer
3
Withdrawn
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)
Last Updated: September 4, 2008
Condition(s): Chronic Lymphocytic Leukemia
4
Active, not recruiting
A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
Last Updated: July 21, 2010
Condition(s): Tumors; Hypoxia
5
Completed
Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
Last Updated: January 14, 2008
Condition(s): Melanoma; Malignant Metastatic Melanoma
6
Withdrawn
Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours
Last Updated: May 13, 2011
Condition(s): Cancer; Advanced Solid Tumours; Lymphomas
7
Active, not recruiting
Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity
Last Updated: April 12, 2012
Condition(s): Neoplasms
8
Completed
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
Last Updated: October 1, 2010
Condition(s): Metastatic Melanoma
9
Active, not recruiting
Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma
Last Updated: October 11, 2011
Condition(s): Smoldering Multiple Myeloma
10
Recruiting
Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse
Last Updated: October 28, 2011
Condition(s): Patients With Multiple Myeloma Experiencing a; First or Second Relapse
11
Active, not recruiting
A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
Last Updated: June 17, 2011
Condition(s): Squamous Cell Carcinoma of the Head and Neck
12
Recruiting
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Last Updated: May 24, 2012
Condition(s): Advanced Solid Tumors
13
Active, not recruiting
MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
Last Updated: January 5, 2012
Condition(s): Metastatic Colorectal Cancer
14
Active, not recruiting
A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.
Last Updated: January 17, 2012
Condition(s): Cancer
15
Active, not recruiting
A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors
Last Updated: May 18, 2012
Condition(s): Cancer
16
Completed
A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
Last Updated: June 2, 2009
Condition(s): Breast Cancer
17
Terminated
Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer
Last Updated: January 20, 2011
Condition(s): Metastatic Colorectal Cancer
18
Recruiting
Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors
Last Updated: December 8, 2011
Condition(s): Cancer
19
Active, not recruiting
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
Last Updated: February 4, 2011
Condition(s): Squamous Cell Carcinoma of the Head and Neck
20
Completed
RNA-Loaded Dendritic Cell Cancer Vaccine
Last Updated: January 3, 2012
Condition(s): Renal Cell Carcinoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Anti-tumor+activity

Page 1 of Clinical Trials for Anti-tumor activity, 1159 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About